{"id":"W4283031673","doi":"10.1038/s41591-022-01867-3","title":"Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial","year":2022,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":276,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"Novartis Institutes for BioMedical Research; Genentech; New South Wales Government; University of Sydney; Sarepta Therapeutics; University of New South Wales; Biogen; Children's Medical Research","keywords":"Spinal muscular atrophy; Medicine; Atrophy; Pediatrics; Internal medicine; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001023168,0.0002822994,0.0007670237,0.0001803349,0.0004627253,0.000005797685,0.0003475563,0.0001334515,0.0003178776],"category_scores_gemma":[0.0007119829,0.000157852,0.0002923346,0.000384481,0.0004163031,0.00002346135,0.0001531421,0.0006870318,0.000001121707],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009833794,"about_ca_system_score_gemma":0.0003042066,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008897519,"about_ca_topic_score_gemma":0.0001292835,"domain_scores_codex":[0.9970904,0.0001261656,0.0005082017,0.0004594892,0.001352474,0.000463277],"domain_scores_gemma":[0.9980772,0.0004214734,0.0003009594,0.0007364451,0.0002885867,0.000175395],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.855443,0.002787897,0.004767318,0.002440581,0.003636088,0.0001566275,0.001558071,0.0002507025,0.04761305,0.001310261,0.02745388,0.05258252],"study_design_scores_gemma":[0.6752898,0.08138888,0.006674641,0.0004642202,0.004051913,0.0002791158,0.0009248416,0.003906773,0.01697957,0.0009330507,0.2085799,0.0005274011],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9725339,0.0128676,0.002460444,0.003090162,0.0004045283,0.008306962,0.000177684,0.00003364659,0.0001250891],"genre_scores_gemma":[0.9953016,0.0002003611,0.0008240986,0.0007456015,0.0006636995,0.001586774,0.0002144039,0.00006412362,0.0003993208],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.181126,"threshold_uncertainty_score":0.6437017,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02039266236607381,"score_gpt":0.3519006474677333,"score_spread":0.3315079851016595,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}